ACCORD HEALTHCARE, INC. Levothyroxine Sodium Tablets, USP Recall
ACCORD HEALTHCARE, INC. Levothyroxine Sodium Tablets, USP are being recalled nationwide in the United States due to subpotent drug potency. The affected lots are D2402443, D2402444, and D2402445 with an expiration date of 10/31/2026, and the products are packaged in 90-count and 1000-count bottles. The recall is being overseen by the FDA.
| Brand | ACCORD HEALTHCARE, INC. |
|---|---|
| Product | Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-452-17. |
| Reason | Subpotent Drug |
| Severity | moderate |
| Units affected | N/A |
| Distribution | Nationwide within the United States |
| Agency | FDA |
WHAT YOU SHOULD DO
- Do not use any Levothyroxine tablets from the recalled lots (D2402443, D2402444, D2402445) expiring 10/31/2026.
- Set the recalled bottles aside and contact Accord Healthcare, Inc. or your pharmacy to arrange return, replacement, or refund per their instructions.
- Retain the product packaging and note the lot number and expiration date for reference.
- Consult your healthcare provider if you have questions about thyroid management or symptoms.
How to identify the recalled item
| Lot / date codes | Lot #: D2402443, D2402444, D2402445, Exp. Date 10/31/2026. |
|---|---|
| Lot / date codes | a) Lot # D2402430, D2402431, Exp Date: 10/31/2026. b) Lot #: D2402432, Exp. Date 10/31/2026; D2500180, Exp. Date 12/31/2026. |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.